清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): A randomized double-blind placebo-controlled pilot clinical trial

医学 安慰剂 双盲 麻醉 缺血性中风 随机对照试验 临床试验 药丸 内科学 缺血 药理学 病理 替代医学
作者
Shengde Li,Anxin Wang,Lin Shi,Qin Liu,Xiaoling Guo,Kun Liu,Xiaoli Wang,Jie Li,Jianming Zhu,Qiuyi Wu,Qingcheng Yang,Xianbo Zhuang,Hui You,Feng Feng,Yishan Luo,Huiling Li,Jun Ni,Bin Peng
出处
期刊:Chinese Medical Journal [Lippincott Williams & Wilkins]
卷期号:138 (5): 579-588 被引量:9
标识
DOI:10.1097/cm9.0000000000003133
摘要

BACKGROUND: Preclinical studies have indicated that Angong Niuhuang Pills (ANP) reduce cerebral infarct and edema volumes. This study aimed to investigate whether ANP safely reduces cerebral infarct and edema volumes in patients with moderate to severe acute ischemic stroke. METHODS: This randomized, double-blind, placebo-controlled pilot trial included patients with acute ischemic stroke with National Institutes of Health Stroke Scale (NIHSS) scores ranging from 10 to 20 in 17 centers in China between April 2021 and July 2022. Patients were allocated within 36 h after onset via block randomization to receive ANP or placebo (3 g/day for 5 days). The primary outcomes were changes in cerebral infarct and edema volumes after 14 days of treatment. The primary safety outcome was severe adverse events (SAEs) for 90 days. RESULTS: There were 57 and 60 patients finally included in the ANP and placebo groups, respectively for modified intention-to-treat analysis. The median age was 66.0 years, and the median NIHSS score at baseline was 12.0. The changes in cerebral infarct volume at day 14 were 0.3 mL and 0.4 mL in the ANP and placebo groups, respectively (median difference: -7.1 mL; interquartile range [IQR]: -18.3 to 2.3 mL, P = 0.30). The changes in cerebral edema volume of the ANP and placebo groups on day 14 were 11.4 mL and 4.0 mL, respectively ( median difference: 3.0 mL, IQR: -1.3 to 9.9 mL, P = 0.15). The rates of SAE within 90 days were similar in the ANP (3/57, 5%) and placebo (7/60, 12%) groups ( P = 0.36). Changes in serum mercury and arsenic concentrations were comparable. In patients with large artery atherosclerosis, ANP reduced the cerebral infarct volume at 14 days (median difference: -12.3 mL; IQR: -27.7 to -0.3 mL, P = 0.03). CONCLUSIONS: ANP showed a similar safety profile to placebo and non-significant tendency to reduce cerebral infarct volume in patients with moderate-to-severe stroke. Further studies are warranted to assess the efficacy of ANP in reducing cerebral infarcts and improving clinical prognosis. TRAIL REGISTRATION: Clinicaltrials.gov , No. NCT04475328.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被纯情的阁采纳,获得10
2秒前
阳光手机完成签到,获得积分10
16秒前
重要静柏完成签到,获得积分10
22秒前
22秒前
大个的应助被wangruida采纳,获得10
26秒前
27秒前
null的应助被科研通管家采纳,获得10
29秒前
null的应助被科研通管家采纳,获得10
29秒前
29秒前
30秒前
纯情的阁发布了新的文献求助10
31秒前
玩命的怀绿完成签到,获得积分10
33秒前
纯情的阁发布了新的文献求助10
33秒前
纯情的阁发布了新的文献求助10
35秒前
wangruida完成签到,获得积分10
40秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
43秒前
44秒前
wangruida发布了新的文献求助10
47秒前
清爽水之完成签到,获得积分10
53秒前
科研通AI6.2的应助被纯情的阁采纳,获得30
1分钟前
舒心鞋垫完成签到,获得积分10
1分钟前
合适的千秋完成签到,获得积分10
1分钟前
xun完成签到,获得积分10
1分钟前
1分钟前
脑洞疼的应助被xun采纳,获得10
1分钟前
酷炫梦山完成签到,获得积分10
1分钟前
郭橐驼完成签到 ,获得积分10
1分钟前
1分钟前
美满的幻竹完成签到,获得积分10
1分钟前
陶醉的莫茗完成签到,获得积分10
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
xun发布了新的文献求助10
1分钟前
夏雪儿发布了新的文献求助10
1分钟前
纯情的阁发布了新的文献求助30
1分钟前
上官若男的应助被xun采纳,获得10
1分钟前
夏雪儿完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158935
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719383
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552013
邀请新用户注册赠送积分活动 2471370